Evidence map›Paper›PMID 37556014›Full record

ArticleBiometals : an international journal on the role of metal ions in biology, biochemistry, and medicine2023

Myco-fabricated ZnO nanoparticles ameliorate neurotoxicity in mice model of Alzheimer's disease via acetylcholinesterase inhibition and oxidative stress reduction.

Hanan A Abd Elmonem, Reham M Morsi, Doaa S Mansour, El-Sayed R El-Sayed

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Nano-structured strategies in combatting neurodegeneration.Frontiers in bioengineering and biotechnology · 2025
    Review
  3. Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Hanan A Abd ElmonemBiological Applications Department, Nuclear Research Center, Egyptian Atomic Energy Authority, Cairo, Egypt.
Reham M MorsiBiological Applications Department, Nuclear Research Center, Egyptian Atomic Energy Authority, Cairo, Egypt.
Doaa S MansourBiological Applications Department, Nuclear Research Center, Egyptian Atomic Energy Authority, Cairo, Egypt.
El-Sayed R El-SayedPlant Research Department, Nuclear Research Center, Egyptian Atomic Energy Authority, Cairo, Egypt. sayed_zahran2000@yahoo.com.
Egyptian Atomic Energy Authority · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is one of the primary health problems linked to the decrease of acetylcholine in cholinergic neurons and elevation in oxidative stress. Myco-fabrication of ZnO-NPs revealed excellent biological activities, including anti-inflammatory and acetylcholinesterase inhibitory potentials. This study aims to determine if two distinct doses of myco-fabricated ZnO-NPs have a positive impact on behavioral impairment and several biochemical markers associated with inflammation and oxidative stress in mice that have been treated by aluminum chloride (AlCl

Indexed as

Alzheimer DiseaseZinc OxideAcetylcholinesteraseAluminum CompoundsAnimalsChloridesGlutathioneMaleMiceOxidative StressAcetylcholinesteraseAluminum CompoundsChloridesGlutathioneZinc OxideAlzheimer’s diseaseMiceMyco-fabricationNeurotoxicityZnO nanoparticles

Identifiers

PMID37556014
PMCPMC10684416
OpenAlexW4385683551

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.